Veerhealth Care Limited (BOM:511523)
India
· Delayed Price · Currency is INR 18.54
+0.26 (1.42%)
At close: Jun 27, 2025
Veerhealth Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 166.71 | 132.23 | 132.73 | 96.26 | 105.8 | Upgrade
|
Other Revenue | 12.19 | 9.9 | 9.41 | 11.73 | 7.9 | Upgrade
|
| 178.89 | 142.13 | 142.14 | 107.99 | 113.7 | Upgrade
| |
Revenue Growth (YoY) | 25.86% | -0.00% | 31.62% | -5.02% | -3.23% | Upgrade
|
Cost of Revenue | 113.99 | 92.56 | 94.75 | 71.27 | 75.16 | Upgrade
|
Gross Profit | 64.9 | 49.57 | 47.39 | 36.73 | 38.54 | Upgrade
|
Selling, General & Admin | 15.78 | 15.38 | 12.87 | 11.79 | 8.28 | Upgrade
|
Other Operating Expenses | 32.32 | 18.2 | 20.14 | 21.41 | 21.7 | Upgrade
|
Operating Expenses | 57.18 | 40.69 | 39.22 | 38.44 | 34.65 | Upgrade
|
Operating Income | 7.72 | 8.88 | 8.17 | -1.72 | 3.89 | Upgrade
|
Interest Expense | -2.64 | - | - | -0.45 | -2.11 | Upgrade
|
Interest & Investment Income | - | 3.99 | 2.99 | 4.94 | 4.07 | Upgrade
|
Other Non Operating Income (Expenses) | - | -0.08 | -0.01 | -0.41 | -0.08 | Upgrade
|
EBT Excluding Unusual Items | 5.08 | 12.8 | 11.14 | 2.38 | 5.77 | Upgrade
|
Gain (Loss) on Sale of Assets | - | 0.02 | 0.03 | - | - | Upgrade
|
Pretax Income | 5.08 | 12.82 | 11.17 | 2.38 | 5.77 | Upgrade
|
Income Tax Expense | 1.16 | 8.75 | -4.65 | 3.11 | 1.98 | Upgrade
|
Net Income | 3.91 | 4.06 | 15.82 | -0.74 | 3.79 | Upgrade
|
Net Income to Common | 3.91 | 4.06 | 15.82 | -0.74 | 3.79 | Upgrade
|
Net Income Growth | -3.62% | -74.33% | - | - | 19.13% | Upgrade
|
Shares Outstanding (Basic) | 20 | 20 | 20 | 14 | 14 | Upgrade
|
Shares Outstanding (Diluted) | 20 | 20 | 20 | 14 | 14 | Upgrade
|
Shares Change (YoY) | -2.14% | - | 44.20% | - | 0.00% | Upgrade
|
EPS (Basic) | 0.20 | 0.20 | 0.79 | -0.05 | 0.27 | Upgrade
|
EPS (Diluted) | 0.20 | 0.20 | 0.79 | -0.05 | 0.27 | Upgrade
|
EPS Growth | -1.51% | -74.33% | - | - | 19.13% | Upgrade
|
Free Cash Flow | -92.02 | 20.7 | -27.85 | 2.25 | 5.06 | Upgrade
|
Free Cash Flow Per Share | -4.70 | 1.03 | -1.39 | 0.16 | 0.36 | Upgrade
|
Gross Margin | 36.28% | 34.88% | 33.34% | 34.01% | 33.89% | Upgrade
|
Operating Margin | 4.31% | 6.25% | 5.75% | -1.59% | 3.42% | Upgrade
|
Profit Margin | 2.19% | 2.86% | 11.13% | -0.68% | 3.33% | Upgrade
|
Free Cash Flow Margin | -51.44% | 14.56% | -19.59% | 2.08% | 4.45% | Upgrade
|
EBITDA | 16.8 | 16 | 14.39 | 3.53 | 8.57 | Upgrade
|
EBITDA Margin | 9.39% | 11.25% | 10.12% | 3.26% | 7.54% | Upgrade
|
D&A For EBITDA | 9.08 | 7.12 | 6.22 | 5.24 | 4.68 | Upgrade
|
EBIT | 7.72 | 8.88 | 8.17 | -1.72 | 3.89 | Upgrade
|
EBIT Margin | 4.31% | 6.25% | 5.75% | -1.59% | 3.42% | Upgrade
|
Effective Tax Rate | 22.92% | 68.31% | - | 130.98% | 34.25% | Upgrade
|
Revenue as Reported | 178.89 | 146.13 | 145.13 | 112.94 | 117.77 | Upgrade
|
Advertising Expenses | - | 2.28 | 3.67 | 2.92 | 0.7 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.